ConductScience.org, home

Paper20680652

OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users.

Becker ML and 5 others. Neurogenetics, 2011. Cited by 49 papers, by iCite.

Cite this record

ConductScience Library. OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users. Papers, record 20680652. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20680652

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
OCT1 polymorphism is associated with response and survival time in anti-Parkinsonian drug users.
PubMed
Journal
Neurogenetics
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
49
iCite
Relative citation ratio, by iCite
1.59
iCite
Revised in PubMed
2022-03-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Becker MLMatthijs L
2Visser LELoes E
3van Schaik RHRon H N
4Hofman AAlbert
5Uitterlinden AGAndré G
6Stricker BHBruno H Ch

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiparkinson AgentsMajor topic
Organic Cation Transporter 1Major topic
Parkinson DiseaseMajor topic
Polymorphism, Single NucleotideMajor topic
Aged
Aged, 80 and over
Alleles
Cohort Studies
Female
Humans
Levodopa
Male
Pharmacogenetics
Proportional Hazards Models
Survival Analysis

Source PubMed

Download CSV of topics

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111191835Apical uptake of organic cations by human intestinal Caco-2 cells: putative involvement of ASF transporters.Naunyn Schmiedebergs Arch Pharmacol2001https://conductscience.org/library/papers/11191835PubMed
219728115The Rotterdam Study: 2010 objectives and design update.Eur J Epidemiol2009https://conductscience.org/library/papers/19728115PubMed
312438515The cation transporters rOCT1 and rOCT2 interact with bicarbonate but play only a minor role for amantadine uptake into rat renal proximal tubules.J Pharmacol Exp Ther2002https://conductscience.org/library/papers/12438515PubMed
414576340Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3).J Pharmacol Exp Ther2004https://conductscience.org/library/papers/14576340PubMed
517307202Blood-brain barrier transport of pramipexole, a dopamine D2 agonist.Life Sci2007https://conductscience.org/library/papers/17307202PubMed
614685227The International HapMap Project.Nature2003https://conductscience.org/library/papers/14685227PubMed
79204539Opossum kidney cells take up L-DOPA through an organic cation potential-dependent and proton-independent transporter.Cell Biol Int1997https://conductscience.org/library/papers/9204539PubMed
88762102Studies on the pharmacology of the inward transport of L-DOPA in rat renal tubules.Br J Pharmacol1996https://conductscience.org/library/papers/8762102PubMed
917473959Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications.Pharm Res2007https://conductscience.org/library/papers/17473959PubMed
109776363Catecholamine transport by the organic cation transporter type 1 (OCT1).Br J Pharmacol1998https://conductscience.org/library/papers/9776363PubMed
1119381165Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus.Pharmacogenomics J2009https://conductscience.org/library/papers/19381165PubMed
1215640376Transport of the dopamine D2 agonist pramipexole by rat organic cation transporters OCT1 and OCT2 in kidney.Drug Metab Dispos2005https://conductscience.org/library/papers/15640376PubMed

Download CSV of references

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 49 citations.

PMIDTitleJournalYearIn PapersSource
40201683Multigenetic pharmacogenomics-guided treatment shows greater improvements on motor symptoms compared to usual therapy in Parkinson's disease: a small real-word prospective cohort study.Front Pharmacol2025https://conductscience.org/library/papers/40201683PubMed
39403148Longitudinal assessment of SNPs rs72552763 and rs622342 in SLC22A1 over HbA1c control among Mexican-Mestizo diabetic type 2 patients.Front Pharmacol2024https://conductscience.org/library/papers/39403148PubMed
36582064Pharmacogenomics-a New Frontier for Individualized Treatment of Parkinson's Disease.Curr Neuropharmacol2023https://conductscience.org/library/papers/36582064PubMed
36297437Polymorphism of Drug Transporters, Rather Than Metabolizing Enzymes, Conditions the Pharmacokinetics of Rasagiline.Pharmaceutics2022https://conductscience.org/library/papers/36297437PubMed
35754508High Affinity Decynium-22 Binding to Brain Membrane Homogenates and Reduced Dorsal Camouflaging after Acute Exposure to it in Zebrafish.Front Pharmacol2022https://conductscience.org/library/papers/35754508PubMed
35336971Dengue Virus Replication Is Associated with Catecholamine Biosynthesis and Metabolism in Hepatocytes.Viruses2022https://conductscience.org/library/papers/35336971PubMed
34834946Association of Hepatitis C Virus Replication with the Catecholamine Biosynthetic Pathway.Viruses2021https://conductscience.org/library/papers/34834946PubMed
34495395Substrates and Inhibitors of Organic Cation Transporters (OCTs) and Plasma Membrane Monoamine Transporter (PMAT) and Therapeutic Implications.Handb Exp Pharmacol2021https://conductscience.org/library/papers/34495395PubMed
34281267A Systematic Review of Parkinson's Disease Pharmacogenomics: Is There Time for Translation into the Clinics?Int J Mol Sci2021https://conductscience.org/library/papers/34281267PubMed
34025422Effects of a Common Eight Base Pairs Duplication at the Exon 7-Intron 7 Junction on Splicing, Expression, and Function of OCT1.Front Pharmacol2021https://conductscience.org/library/papers/34025422PubMed
33674914Organic Cation Transporter (OCT/OCTN) Expression at Brain Barrier Sites: Focus on CNS Drug Delivery.Handb Exp Pharmacol2021https://conductscience.org/library/papers/33674914PubMed
31231590The influence of SLC22A1 rs622342 and ABCC8 rs757110 genetic variants on the efficacy of metformin and glimepiride combination therapy in Egyptian patients with type 2 diabetes.J Drug Assess2019https://conductscience.org/library/papers/31231590PubMed
30745869Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease.Front Pharmacol2019https://conductscience.org/library/papers/30745869PubMed
30363349Pharmacogenetics of Parkinson's Disease in Clinical Practice.Mov Disord Clin Pract2017https://conductscience.org/library/papers/30363349PubMed
29659532Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition.J Pers Med2018https://conductscience.org/library/papers/29659532PubMed
29356624From Genomics to Omics Landscapes of Parkinson's Disease: Revealing the Molecular Mechanisms.OMICS2018https://conductscience.org/library/papers/29356624PubMed
29305687Genetics and Treatment Response in Parkinson's Disease: An Update on Pharmacogenetic Studies.Neuromolecular Med2018https://conductscience.org/library/papers/29305687PubMed
27447939Transporters as Drug Targets in Neurological Diseases.Clin Pharmacol Ther2016https://conductscience.org/library/papers/27447939PubMed
26526073Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses, and drug-drug interactions.Pharmacogenomics J2015https://conductscience.org/library/papers/26526073PubMed
25455070The role of glia in stress: polyamines and brain disorders.Psychiatr Clin North Am2014https://conductscience.org/library/papers/25455070PubMed

See all 29 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
SLC22A16580PubTator's text mininghttps://conductscience.org/library/genes/6580NCBI Gene
SLC22A26582PubTator's text mininghttps://conductscience.org/library/genes/6582NCBI Gene
SLC22A36581PubTator's text mininghttps://conductscience.org/library/genes/6581NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20680652

GET https://conductscience.org/api/papers/v1/20680652/cited_by?page=2